Literature DB >> 9467940

Characterization of the mouse Ron/Stk receptor tyrosine kinase gene.

S E Waltz1, C L Toms, S A McDowell, L A Clay, R S Muraoka, E L Air, W Y Sun, M B Thomas, S J Degen.   

Abstract

In an effort to understand the mechanisms governing the regulation of the mouse Ron receptor gene, a mouse genomic library was screened and overlapping clones coding for the Ron gene and flanking DNA were identified. Continuous DNA sequence was obtained for approximately 16.4 kilobases. The gene, from the initiator methionine to the polyadenylation site, is contained within 13 244 basepairs and contains 19 exons. Primer extension analyses were performed to determine the transcription start site of the mouse Ron transcript. Multiple transcription start sites were found which also appear to be used in transfected reporter constructs containing Ron 5' flanking DNA. To determine the location of sites which may be critical for the function of the Ron gene promoter, a series of chimeric genes containing serial deletions of the Ron gene promoter fused to the coding sequences for the chloramphenicol acetyl-transferase gene were constructed. Transient transfection analyses of these hybrid genes into various cell lines demonstrated that two regions of the Ron gene promoter, encompassing nucleotides -585 to -465 and from -465 to -285, are important for expression of this transcript in CMT-93 cells. Further analysis of the Ron promoter utilizing gel mobility shift analyses suggests that regions encompassing nucleotides -585 to - 508 and nucleotides -375 to -285 appear to bind specific proteins which may be involved in the negative and positive regulation, respectively, of the mouse Ron gene.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9467940     DOI: 10.1038/sj.onc.1201508

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  The Ron/STK receptor tyrosine kinase is essential for peri-implantation development in the mouse.

Authors:  R S Muraoka; W Y Sun; M C Colbert; S E Waltz; D P Witte; J L Degen; S J Friezner Degen
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

2.  Macrophage-stimulating protein differently affects human alveolar macrophages from smoker and non-smoker patients: evaluation of respiratory burst, cytokine release and NF-kappaB pathway.

Authors:  Gabriele Gunella; Claudio Bardelli; Angela Amoruso; Ilario Viano; Piero Balbo; Sandra Brunelleschi
Journal:  Br J Pharmacol       Date:  2006-04-24       Impact factor: 8.739

3.  Biological effects of targeted inactivation of hepatocyte growth factor-like protein in mice.

Authors:  J A Bezerra; T L Carrick; J L Degen; D Witte; S J Degen
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

4.  Ron-mediated cytoplasmic signaling is dispensable for viability but is required to limit inflammatory responses.

Authors:  S E Waltz; L Eaton; K Toney-Earley; K A Hess; B E Peace; J R Ihlendorf; M H Wang; K H Kaestner; S J Degen
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

Review 5.  Met-related receptor tyrosine kinase Ron in tumor growth and metastasis.

Authors:  Purnima K Wagh; Belinda E Peace; Susan E Waltz
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

Review 6.  Ron receptor tyrosine kinase signaling as a therapeutic target.

Authors:  Nancy M Benight; Susan E Waltz
Journal:  Expert Opin Ther Targets       Date:  2012-07-26       Impact factor: 6.902

7.  Friend Spleen Focus-Forming Virus Activates the Tyrosine Kinase sf-Stk and the Transcription Factor PU.1 to Cause a Multi-Stage Erythroleukemia in Mice.

Authors:  Joan Cmarik; Sandra Ruscetti
Journal:  Viruses       Date:  2010-10-11       Impact factor: 5.818

8.  Intron retention in the alternatively spliced region of RON results from weak 3' splice site recognition.

Authors:  Lindsay D Smith; Christian M Lucas; Ian C Eperon
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240

9.  Blocking Short-Form Ron Eliminates Breast Cancer Metastases through Accumulation of Stem-Like CD4+ T Cells That Subvert Immunosuppression.

Authors:  Shu-Chin Alicia Lai; Harika Gundlapalli; H Atakan Ekiz; Amanda Jiang; Elvelyn Fernandez; Alana L Welm
Journal:  Cancer Discov       Date:  2021-12-01       Impact factor: 38.272

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.